File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: The value of tumor markers in a mixed tumor, mucinous and neuroendocrine carcinoma of the ovary

TitleThe value of tumor markers in a mixed tumor, mucinous and neuroendocrine carcinoma of the ovary
Authors
Issue Date1989
PublisherAcademic Press. The Journal's web site is located at http://www.elsevier.com/locate/ygyno
Citation
Gynecologic Oncology, 1989, v. 35 n. 2, p. 272-274 How to Cite?
AbstractSerum CA 125 is frequently used to monitor the treatment response and to detect early recurrence during the follow-up of patients who have epithelial ovarian tumors. In this report, the level of serum CA 125 and urinary 5-hydroxyindole acetic acid of a patient with a carcinoid tumor which occurred in association with a mucinous adenocarcinoma of the ovary is described. The level of serum CA 125 decreased despite the presence of a clinically progressive tumor. There was a rise of the 5-hydroxyindole acetic acid level 16 weeks before pelvic recurrence was detected clinically. This indicates that it was the neuroendocrine component, and not the mucinous component of the tumor, that was not responsive to the chemotherapy. The problem of using tumor markers to monitor patients with mixed tumors is discussed.
Persistent Identifierhttp://hdl.handle.net/10722/147839
ISSN
2015 Impact Factor: 4.198
2015 SCImago Journal Rankings: 2.284
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorNgan, HYSen_HK
dc.contributor.authorCollins, RJen_HK
dc.contributor.authorWong, LCen_HK
dc.contributor.authorChan, SYWen_HK
dc.contributor.authorMa, HKen_HK
dc.date.accessioned2012-05-29T06:09:30Z-
dc.date.available2012-05-29T06:09:30Z-
dc.date.issued1989en_HK
dc.identifier.citationGynecologic Oncology, 1989, v. 35 n. 2, p. 272-274en_HK
dc.identifier.issn0090-8258en_HK
dc.identifier.urihttp://hdl.handle.net/10722/147839-
dc.description.abstractSerum CA 125 is frequently used to monitor the treatment response and to detect early recurrence during the follow-up of patients who have epithelial ovarian tumors. In this report, the level of serum CA 125 and urinary 5-hydroxyindole acetic acid of a patient with a carcinoid tumor which occurred in association with a mucinous adenocarcinoma of the ovary is described. The level of serum CA 125 decreased despite the presence of a clinically progressive tumor. There was a rise of the 5-hydroxyindole acetic acid level 16 weeks before pelvic recurrence was detected clinically. This indicates that it was the neuroendocrine component, and not the mucinous component of the tumor, that was not responsive to the chemotherapy. The problem of using tumor markers to monitor patients with mixed tumors is discussed.en_HK
dc.languageengen_US
dc.publisherAcademic Press. The Journal's web site is located at http://www.elsevier.com/locate/ygynoen_HK
dc.relation.ispartofGynecologic Oncologyen_HK
dc.subject.meshAdenocarcinoma, Mucinous - Drug Therapy - Pathologyen_US
dc.subject.meshAdulten_US
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols - Therapeutic Useen_US
dc.subject.meshCisplatin - Administration & Dosageen_US
dc.subject.meshCyclophosphamide - Administration & Dosageen_US
dc.subject.meshEndocrine System Diseases - Drug Therapy - Pathologyen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshNeoplasms, Germ Cell And Embryonal - Drug Therapy - Pathologyen_US
dc.subject.meshNervous System Neoplasms - Drug Therapy - Pathologyen_US
dc.subject.meshOvarian Neoplasms - Drug Therapy - Pathologyen_US
dc.subject.meshStaining And Labelingen_US
dc.subject.meshTumor Markers, Biological - Analysisen_US
dc.titleThe value of tumor markers in a mixed tumor, mucinous and neuroendocrine carcinoma of the ovaryen_HK
dc.typeArticleen_HK
dc.identifier.emailNgan, HYS:hysngan@hkucc.hku.hken_HK
dc.identifier.emailCollins, RJ:rcollins@hkucc.hku.hken_HK
dc.identifier.authorityNgan, HYS=rp00346en_HK
dc.identifier.authorityCollins, RJ=rp00251en_HK
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.pmid2478429-
dc.identifier.scopuseid_2-s2.0-0024436128en_HK
dc.identifier.volume35en_HK
dc.identifier.issue2en_HK
dc.identifier.spage272en_HK
dc.identifier.epage274en_HK
dc.identifier.isiWOS:A1989AW22600032-
dc.publisher.placeUnited Statesen_HK
dc.identifier.scopusauthoridNgan, HYS=34571944100en_HK
dc.identifier.scopusauthoridCollins, RJ=7403350455en_HK
dc.identifier.scopusauthoridWong, LC=7402092003en_HK
dc.identifier.scopusauthoridChan, SYW=7404255960en_HK
dc.identifier.scopusauthoridMa, HK=7403095603en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats